Swapnil Bhargava
Chief Tech/Sci/R&D Officer at CG ONCOLOGY, INC.
Profile
Swapnil Bhargava is currently the Chief Technical Officer at CG Oncology, Inc. He previously worked as the SVP-CMC Development & GMP Manufacturing at AbCellera Biologics, Inc. and as the VP-Drug Substance Process Development at Seagen Inc. Dr. Bhargava holds a doctorate degree from the University of Maryland and a graduate degree from the Indian Institute of Technology Delhi.
Swapnil Bhargava active positions
| Companies | Position | Start |
|---|---|---|
| CG ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2023-08-31 |
Former positions of Swapnil Bhargava
| Companies | Position | End |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - |
| ABCELLERA BIOLOGICS INC. | Corporate Officer/Principal | - |
Training of Swapnil Bhargava
| University of Maryland | Doctorate Degree |
| Indian Institute of Technology Delhi | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Swapnil Bhargava
